Gene Sequencing: No Easy Answers

The sequencing of the human genome was discussed by two of its proponents in the October 20, 1986 issue of The Scientist  (pp. 11-12). Their statements were sound and true, but incomplete in that there was no discussion of the social and ethical implications of this profound technological goal, and only good was seen to come from it. In the context of today's entrepreneurial science-technology adventures, this is at best simplistic. Science should learn from experience. That biology is trea

Written byLiebe Cavalieri
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Science should learn from experience. That biology is treading in the footsteps of physics is not a new idea. Physics was in its golden era in the 1920s and 1930s. This period ended abruptly and unexpectedly in December 1938 with the discovery of atomic fission. This is not to imply that the heyday of molecular biology will lead to a parallel scenario, but that the sequencing of the human genome is as portentous an undertaking as the study of atomic structure, and is not merely a technological phenomenon. It will make it possible to insert new genes or change existing ones to "improve" the species, and to predict the likely future course of an individual's health. Given recombinant DNA technology, the knowledge it will provide is unparalleled. Indeed, Walter Gilbert and Walter Bodmer say so in so many words in The Scientist.

I believe that many scientists feel the awesome ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies